Journal
REVISTA VIRTUAL DE QUIMICA
Volume 14, Issue 6, Pages 984-995Publisher
SOC BRASILEIRA QUIMICA
DOI: 10.21577/1984-6835.20220053
Keywords
Psychedelics; entactogens; major depressive disorder
Categories
Ask authors/readers for more resources
This study reviews and compares the pharmacological and molecular aspects of psychedelic indoleamines and entactogen substances, highlighting their potential as novel drugs in the field of psychiatry and as psychotherapy adjuvants. The analysis allows for the contemplation of molecular design strategies for drugs with desirable pharmacological profiles.
Depression and anxiety disorders are a major challenge for modern psychiatry, especially when shown to be resistant to conventional means of treatment. Over the past decade, psychedelic and entactogen substances, once stigmatized, have regained an ever-growing momentum as potential therapeutic agents for these disorders. The present study offers a review and comparison of the pharmacological and molecular aspects of psychedelic indoleamines and entactogen substances that demonstrate potential to become novel drugs in the field of psychiatry and as psychotherapy adjuvants. The analysis of the presented aspects allows for the contemplation of molecular design strategies for novel drugs with desirable pharmacological profiles.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available